Related Experiment Video
Updated: Aug 9, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Metabolic deficiencies in protozoa induced by thalidomide
Science (New York, N.Y.)
|January 11, 1963
Summary
Thalidomide hinders protozoan growth, an effect reversed by nicotinic acid and vitamin K1. This suggests a potential mechanism involving cellular oxidation interference, highlighting protozoa as a model for drug side-effect studies.
Area of Science:
- Pharmacology
- Protozoology
- Biochemistry
Background:
- Thalidomide is known for its teratogenic effects.
- Protozoa are single-celled organisms that share metabolic pathways with higher organisms.
- Understanding drug toxicity mechanisms is crucial for drug development and safety.
Purpose of the Study:
- To investigate the effect of thalidomide on protozoan growth.
- To identify compounds that counteract thalidomide's inhibitory effects on protozoa.
- To explore the potential mechanism of thalidomide's toxicity in a protozoan model.
Main Methods:
- Culturing protozoa and exposing them to thalidomide.
- Testing the efficacy of nicotinic acid, nicotinamide, nicotinamide adenine dinucleotide, and vitamin K1 as counteracting agents.
- Analyzing the impact on cellular oxidation processes.
Main Results:
- Thalidomide demonstrated significant inhibition of protozoan growth.
- Nicotinic acid, nicotinamide, nicotinamide adenine dinucleotide, and vitamin K1 effectively counteracted thalidomide's inhibitory action.
- Evidence suggests thalidomide's toxicity may stem from interference with cellular oxidation.
Conclusions:
- Protozoa serve as a viable model for studying drug side actions.
- Thalidomide's mechanism of toxicity may involve disruption of cellular oxidation.
- Further research into thalidomide's biochemical interactions is warranted.
More Related Videos
09:49Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
08:48In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:12Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...